Skip to main content
. 2024 Dec 30;25:447. doi: 10.1186/s12931-024-03073-w

Fig. 7.

Fig. 7

Crude proportions of reliever-only therapies in Dutch primary care (2010–2021) from the PHARMO data network for males by age group. SAMA (short-acting muscarinic antagonist), SABA (short-acting beta-agonist), SABA-SAMA (combination of SABA and SAMA). Shaded areas represent 95% confidence intervals